Catalyst Wire Dossier Catalyst Wire Dossier

INGREZZA

valbenazine · Neurocrine Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for INGREZZA, covering 2014-01-16 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia [Phase 3]

See pricing